Metriport raised $26 million to help clinicians retrieve patient data more efficiently, using a platform approach aimed at easing the administrative friction behind modern care coordination. The Series A was led by Matrix, with additional backing from ARTIS and Y Combinator. For the biotech and clinical research ecosystem, faster and more complete data retrieval can reduce site burden in trials and improve the ability to operationalize biomarker-driven care. Metriport’s emphasis on clinician workflows signals continued investment in the data plumbing layer that supports trials, real-world evidence, and longitudinal studies. The funding also arrives as multiple companies are competing on interoperability and data access models, making onboarding speed and coverage breadth critical differentiators for customers across healthcare systems and research sponsors.